Massive new database aims to unlock secrets of rare pancreatic cancer
NCT ID NCT07183280
First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This study is creating a large, real-world database for a rare pancreatic tumor called solid pseudopapillary neoplasm (SPN). Researchers will collect data from 2,000 participants to track long-term outcomes like survival and recurrence. The goal is to provide high-quality evidence to improve future clinical care and research.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this database could provide high-quality evidence to guide better treatments and outcomes for people with this rare pancreatic tumor.
- What could go wrong
- This is an observational database study, not a treatment trial. It will not directly test any new therapy, and results depend on data quality and follow-up compliance.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOLID PSEUDOPAPILLARY NEOPLASM OF THE PANCREAS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Shanghai Cancer Center
RECRUITINGShanghai, Special Administrative Region, 200032, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.